))
The Future of Psychedelic Psychotherapy
Manage episode 285216592 series 2828920
Innehåll tillhandahållet av Piers Kaniuka. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Piers Kaniuka eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
In Episode 14 Piers and psychedelic researcher and activist Brett Greene discuss the future of psychedelic psychotherapy. Recorded on February 6, 2021.
Brett Greene is Chief Innovation Officer of Cybin, a leading biotechnology company focused on psychedelic therapeutics. Brett was co-founder of Psymposia a non-profit media organization that offers perspectives on drugs, politics, and culture. He also was the founder of Adelia Therapeutics a biopharmaceutical company dedicated to developing psychedelic therapeutics. You can find him on LinkedIn.
Resistance Recovery (RR) is reimagining addiction, recovery, and community in the 21st century. Piers Kaniuka, MTS, MS has worked with thousands of addicts and alcoholics in his 25+ years in the field. Discover RR's new paradigm of addiction recovery by visiting Resistance Recovery.
Visit the RR YouTube channel: https://www.youtube.com/c/RESISTANCERECOVERY
Sign-up for Long Threads and get Resistance Recovery news: https://mailchi.mp/ddc8023bec67/welcometoresistancerecovery
Support this podcast at — https://redcircle.com/resistance-recovery/donations
58 episoder
Dela
